TrialThe international journal of neuropsychopharmacology2022

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.

Dean Najarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.